Venous thromboembolism is prevalent in hospitalized COVID-19 patients. Through
systematic review and meta-analysis, we have investigated the differences in clinical …

Introduction Venous thromboembolism (VTE) has been observed as a frequent complication
in patients with severe novel coronavirus disease 2019 (COVID-19) infection requiring …

Background: Accumulating evidence suggests that coronavirus disease 2019 (COVID-19) is
associated with hypercoagulative status, particularly for critically ill patients in the intensive …

Abstract Purpose Coronavirus disease‐2019 (COVID‐19) may predispose to venous
thromboembolism (VTE) and arterial thromboembolism because of excessive inflammation …

Introduction: Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection resulting in COVID-19 disease is associated with widespread inflammation and a …

Background High incidence of venous thromboembolic complications in coronavirus
disease 2019 (COVID-19) patients was noted recently. Objective This study aimed to …

Background: A high incidence of venous thromboembolism (VTE) is reported in hospitalized
COVID-19 patients, in particular in patients admitted to the intensive care unit (ICU). In …

Background Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic,
the incidence of thromboembolism has been increasingly reported. The aim of this …

Background Venous thromboembolism (VTE) may complicate the course of Coronavirus
Disease 2019 (COVID-19). Objectives To evaluate the incidence of VTE in patients with …

Objective We have summarized the incidence, anticoagulation panels, laboratory
characteristics, and mortality of venous thromboembolism (VTE) in hospitalized patients with …